Drug Discovery for Parkinson's With Mutations in the GBA Gene
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
The New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate Parkinson's disease research and drug development by using cells from the body (such as skin or blood cells) to make stem cells and other types of cells, conduct research on the samples, perform genetic testing, and/or store the samples for future use. Through this research, researchers hope to identify future treatments or even cures for Parkinson's disease.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
• Age 18 years or older.
• Diagnosis of Parkinson's disease, Gaucher disease, or healthy control.
• Must provide written informed consent unless physical limitations preclude signing.
Locations
United States
New York
The New York Stem Cell Foundation Research Institute
RECRUITING
New York
Contact Information
Primary
Clinical Research Office
clinicalresearch@nyscf.org
212-927-1801
Time Frame
Start Date: 2022-07-15
Estimated Completion Date: 2025-07-15
Participants
Target number of participants: 60
Treatments
Parkinson's Disease
Subjects in this group will have a diagnosis of Parkinson's disease with or without a known GBA gene mutation.
Gaucher Disease
Subjects in this group with have a diagnosis of Gaucher disease with or without a known GBA gene mutation.
Healthy Control
Subjects in this group will serve as healthy controls.
Related Therapeutic Areas
Sponsors
Collaborators: Silverstein Foundation
Leads: New York Stem Cell Foundation Research Institute